Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aryeh Fischer

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Current Medical Research and Opinion|July 23, 2019
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and managementMarlies Wijsenbeek, Michael Kreuter, Amy Olson, et al.
American Journal of Respiratory and Critical Care Medicine|September 21, 2010
Rheumatoid arthritis-interstitial lung disease-associated mortalityAmy L Olson, Jeffrey J Swigris, David B Sprunger, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 4, 2018
State of the art in interstitial pneumonia with autoimmune features: a systematic review on retrospective studies and suggestions for further advancesGianluca Sambataro, Domenico Sambataro, Sebastiano Emanuele Torrisi, et al.
The Lancet. Respiratory Medicine|October 4, 2019
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trialToby M Maher, Tamera J Corte, Aryeh Fischer, et al.
Chest|April 12, 2008
Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survivalAryeh Fischer, Jeffrey J Swigris, Steve D Groshong, et al.
Chest|April 12, 2007
Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung diseaseAryeh Fischer, Shigeki Misumi, Douglas Curran-Everett, et al.
Respiratory Medicine|June 25, 2013
Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD)Joshua J Solomon, Jay H Ryu, Henry D Tazelaar, et al.
Respiratory Medicine|April 16, 2013
FEV1 over time in patients with connective tissue disease-related bronchiolitisEvans R Fernández Pérez, Mahalakshmi Krishnamoorthy, Kevin K Brown, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2013
Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibodyChristopher A Czaja, Patricia A Merkel, Edward D Chan, et al.
Chest|April 28, 2009
Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosisJeffrey J Swigris, Jeff Swick, Frederick S Wamboldt, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Current Medical Research and Opinion|July 23, 2019
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and managementMarlies Wijsenbeek, Michael Kreuter, Amy Olson, et al.
American Journal of Respiratory and Critical Care Medicine|September 21, 2010
Rheumatoid arthritis-interstitial lung disease-associated mortalityAmy L Olson, Jeffrey J Swigris, David B Sprunger, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 4, 2018
State of the art in interstitial pneumonia with autoimmune features: a systematic review on retrospective studies and suggestions for further advancesGianluca Sambataro, Domenico Sambataro, Sebastiano Emanuele Torrisi, et al.
The Lancet. Respiratory Medicine|October 4, 2019
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trialToby M Maher, Tamera J Corte, Aryeh Fischer, et al.
Chest|April 12, 2008
Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survivalAryeh Fischer, Jeffrey J Swigris, Steve D Groshong, et al.
Chest|April 12, 2007
Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung diseaseAryeh Fischer, Shigeki Misumi, Douglas Curran-Everett, et al.
Respiratory Medicine|June 25, 2013
Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD)Joshua J Solomon, Jay H Ryu, Henry D Tazelaar, et al.
Respiratory Medicine|April 16, 2013
FEV1 over time in patients with connective tissue disease-related bronchiolitisEvans R Fernández Pérez, Mahalakshmi Krishnamoorthy, Kevin K Brown, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2013
Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibodyChristopher A Czaja, Patricia A Merkel, Edward D Chan, et al.
Chest|April 28, 2009
Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosisJeffrey J Swigris, Jeff Swick, Frederick S Wamboldt, et al.
Pageof 11